Clarke 2013.
Methods | Design: randomised control trial |
Participants |
Participants: individuals with personality disorder referred to a specialist outpatient service Sex:a 28 men, 71 women Age:a mean age = 36.0 years (SD = 9.5, range = 19‐59) Unit of allocation: individual, stratified by cluster Number randomised: experimental group (n = 50); control/TAU group (n = 49) Number completing: experimental group (n = 38), control/TAU group (n = 40) Setting: specialist outpatient clinic of public health service (NHS, UK) Inclusion criteria: participants met diagnostic criteria for a personality disorder; participants had completed at least one previous episode of therapy (see note 2) Exclusion criteria: diagnosis of psychotic illness, substance dependence or intellectual disability based on DSM‐IV criteria; participant reports self‐harming behaviour on at least a monthly basis Ethnicity: not stated Baseline characteristics:a 88% of the sample had a diagnosis of two or more personality disorders; 53% displayed diagnoses across two clusters; 28% across all three clusters; 68% of participants had a diagnosis of borderline personality disorder |
Interventions | Two conditions: cognitive analytic therapy (CAT); or treatment‐as‐usual (TAU)
Details of conditions:
Duration of intervention: 24 sessions Duration of trial: 10 months Length of follow‐up: 12 months |
Outcomes |
Secondary outcomes
Other outcomes
|
Notes | aFor all of those randomised (n = 99) at least 18 participants had a cluster B personality disorder. Author (Susan Clarke) contacted by email on 19 January 2017 with request to identify the number of participants with AsPD; no data for AsPD subset. No response received (Clarke 2013) |